Our results suggest a critical role for IL-6, present in ovarian cancer ascites, in promoting highly functional TNFR2+ Tregs, which are shown to be the only Treg subset capable of suppressing TNFR2+ Teffs in ovarian cancer ascites cultures. This evidence concerns the gene IL6 and ovarian carcinoma.